Guo Ziquan, Huang Yong, Jiang Hua, Wang Wenbin
Department of TCM, Southern Medical University, Guangzhou 510515, Guangdong Province, China; People's Hospital of Qionghai, Hainan Province.
Department of TCM, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
Zhongguo Zhen Jiu. 2018 May 12;38(5):4933-8. doi: 10.13703/j.0255-2930.2018.05.011.
To observe the effect of early acupuncture intervention on brain edema in patients with traumatic intracerebral hematoma and explore its mechanism on the basis of conventional western medicine.
With stratified block randomization, sixty-four patients with glasgow coma scale (GCS) of 6 to 12 were divided into an acupuncture combined with medicine group (a combination group) and a western medication group, 32 cases in each one. In the western medication group, dehydration to reduce intracranial pressure and nutritional nerves were given as the basic treatment. In the combination group, on the basis of the treatment as the western medication group, acupuncture was applied at Xuehai (SP 10), Taixi (KI 3), Fenglong (ST 40), Yinlingquan (SP 9), Zusanli (ST 36), etc. The treatment was given once every day, for 6 times as one course; there was an interval of 1 day between two courses; a total of 4 courses were required. GCS score and recovery time were recored before treatment and on the 7 th, 14 th and 28 th days. 90 days follow-up after treatment, the GOS was observed, and the mortality and effective survival rate were calculated. The Barthel index (BI) score was evaluated before treatment and on the 14th, 21st, 28th days and 90 days follow-up after treatment. Before treatment and 3rd, 7th, 14th, 21st, 28th days, cranial CT or MR scan was performed to calculate the brain edema index (BEI); Plasma interleukin-6 (6IL-6), neuropeptide Y (NPY) and nitric oxide (NO) were measured before treatment and on the 3rd, 7th and 14th days after treatment.
(1) The GCS scores increased gradually in the two groups during treatment, and there was significant difference between the 28th days and before treatment (both <0.05). There were no significant difference between the two groups about GCS score and average recovery time on the 28th days treatment (all >0.05). (2) The mortality rate of the combination group was 6.3% (2/32) on 90 days follow-up, 9.4% (3/32) in the western medication group (>0.05). The effective survival rate was 81.3% (26/32) in the combination group, which was higher than 59.4% (19/32) in the western medication group (<0.05). (3) The BI score was significantly higher than that before treatment on the 28th days and 90 days follow-up in the two groups (all <0.05), and the result in the combination group was superior to that in the western medication group (both <0.05). (4) The BEI decreased on the 14th, 21st and 28th days in the two groups (all <0.05), and on the 14th day, the BEI decreased more significantly in the combination group than that in the western medication group (<0.05). (5) The levels of IL-6, NPY and NO decreased on the 7th and 14th days in the two groups (all <0.05), and decreased more significantly in the combination group than that in the western medication group on the 7th day (<0.05).
On the basis of conventional western medicine, early acupuncture can reduce cerebral edema and improve the prognosis of patients, and acupuncture combined with medicine are superior to western medicine alone. Acupuncture mechanism may be related to reducing the expression of inflammatory response.
观察早期针刺干预对外伤性脑内血肿患者脑水肿的影响,并在西医常规治疗基础上探讨其作用机制。
采用分层区组随机化方法,将64例格拉斯哥昏迷量表(GCS)评分6~12分的患者分为针药结合组和西药组,每组32例。西药组给予脱水降颅压及营养神经等基础治疗。针药结合组在西药组治疗基础上,针刺血海(SP10)、太溪(KI3)、丰隆(ST40)、阴陵泉(SP9)、足三里(ST36)等穴位。每日治疗1次,6次为1个疗程;两个疗程之间间隔1天;共需治疗4个疗程。记录治疗前及治疗第7天、14天、28天的GCS评分及恢复时间。治疗后90天随访,观察格拉斯哥预后评分(GOS),计算死亡率及有效生存率。治疗前及治疗后第14天、21天、28天、90天随访时评估巴氏指数(BI)评分。治疗前及治疗后第3天、7天、14天、21天、28天进行头颅CT或磁共振扫描,计算脑水肿指数(BEI);检测治疗前及治疗后第3天、7天、14天的血浆白细胞介素-6(IL-6)、神经肽Y(NPY)和一氧化氮(NO)水平。
(1)两组治疗期间GCS评分均逐渐升高,治疗第28天与治疗前比较差异均有统计学意义(均P<0.05)。治疗第28天时两组GCS评分及平均恢复时间比较差异均无统计学意义(均P>0.05)。(2)针药结合组90天随访死亡率为6.3%(2/32),西药组为9.4%(3/32),差异无统计学意义(P>0.05)。针药结合组有效生存率为81.3%(26/32),高于西药组的59.4%(19/32),差异有统计学意义(P<0.05)。(3)两组治疗第28天及90天随访时BI评分均显著高于治疗前(均P<0.05),且针药结合组优于西药组(均P<0.05)。(4)两组治疗第14天、21天、28天时BEI均降低(均P<0.05),治疗第14天时针药结合组BEI降低幅度大于西药组,差异有统计学意义(P<0.05)。(5)两组治疗第7天、14天时IL-6、NPY、NO水平均降低(均P<0.05),治疗第7天时针药结合组降低幅度大于西药组,差异有统计学意义(P<0.05)。
在西医常规治疗基础上,早期针刺可减轻脑水肿,改善患者预后,针药结合优于单纯西药治疗。针刺机制可能与降低炎症反应表达有关。